The Asia Pacific Rare Diseases Treatment Market would witness market growth of 12.9% CAGR during the forecast period (2022-2028).
Many unprecedented opportunities are expected to turn scientific discoveries into efficient treatments for a large number of people living with rare diseases in the United States. Despite these advances in science, more than 90% of rare diseases remain untreatable. New data & genetics technologies have resulted in the development of the first truly transformative new treatments for a small number of rare diseases.
Due to this, it is required to move more quickly so that no disease or patient is left behind in terms of access to safe & effective therapeutics. The scientific landscape for rare diseases is changing rapidly, and this trend is expected to continue. Rare disease patients are increasingly going to benefit from innovative therapeutics, some of which are the result of breakthrough medical technologies.
While rare diseases are uncommon in and of themselves, they are estimated to affect a large number of people in the United States or one out of every ten Americans. The majority of rare diseases are fatal or severely disabling to children. Because of this significant unmet need, it is critical to find ways to accelerate the therapy development process so that the healthcare sector could address many patients and families who are looking for better treatments for rare diseases.
Asia Pacific region is increasing rare disease treatment offerings as a result of significant unmet medical needs and an increase in the prevalence of rare diseases such as rare cancer, rare cardiovascular problems, and infectious diseases. Because of their large populations and better management in response to the spread of COVID-19, countries in the region have benefited from the advantages of investing in rare disease treatments. A large urban population and an increase in diagnostic services would continue in the Asia-Pacific region for future years. As a result, hospital admissions may increase, and more data will be collected.
The China market dominated the Asia Pacific Rare Diseases Treatment Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $21,241.5 million by 2028. The Japan market is poised to grow at a CAGR of 12.3% during (2022 - 2028). Additionally, The India market is experiencing a CAGR of 13.6% during (2022 - 2028).
Based on Distribution Channel, the market is segmented into Specialty Pharmacy, Hospital Pharmacy, and Online Pharmacy. Based on Route of Administration, the market is segmented into Injectable, Oral, and Others. Based on Therapeutic Area, the market is segmented into Cancer, Cardiovascular Conditions, Infectious Diseases, Musculoskeletal Conditions, Endocrine Disorders, Metabolic Disorders, Hematologic Disorders, Neurological Conditions, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Rare Diseases Treatment Market is Projected to reach USD 255.4 Billion by 2028, at a CAGR of 12.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AbbVie, Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, Merck Group, Bristol Myers Squibb Company, Pfizer, Inc., AstraZeneca PLC, Takeda Pharmaceutical Company Limited and PTC Therapeutics, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Drug Type
- Biologics
- Biosimilar
- Small Molecule
By Distribution Channel
- Specialty Pharmacy
- Hospital Pharmacy
- Online Pharmacy
By Route of Administration
By Therapeutic Area
- Cancer
- Cardiovascular Conditions
- Infectious Diseases
- Musculoskeletal Conditions
- Endocrine Disorders
- Metabolic Disorders
- Hematologic Disorders
- Neurological Conditions
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- AbbVie, Inc.
- F. Hoffmann-La Roche Ltd.
- Bayer AG
- Novartis AG
- Merck Group
- Bristol Myers Squibb Company
- Pfizer, Inc.
- AstraZeneca PLC
- Takeda Pharmaceutical Company Limited
- PTC Therapeutics, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Rare Diseases Treatment Market, by Drug Type
1.4.2 Asia Pacific Rare Diseases Treatment Market, by Distribution Channel
1.4.3 Asia Pacific Rare Diseases Treatment Market, by Route of Administration
1.4.4 Asia Pacific Rare Diseases Treatment Market, by Therapeutic Area
1.4.5 Asia Pacific Rare Diseases Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Acquisition and Mergers
3.2.3 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2018, Jul – 2022, Aug) Leading Players
Chapter 4. Asia Pacific Rare Diseases Treatment Market by Drug Type
4.1 Asia Pacific Biologics Market by Country
4.2 Asia Pacific Biosimilar Market by Country
4.3 Asia Pacific Small Molecule Market by Country
Chapter 5. Asia Pacific Rare Diseases Treatment Market by Distribution Channel
5.1 Asia Pacific Specialty Pharmacy Market by Country
5.2 Asia Pacific Hospital Pharmacy Market by Country
5.3 Asia Pacific Online Pharmacy Market by Country
Chapter 6. Asia Pacific Rare Diseases Treatment Market by Route of Administration
6.1 Asia Pacific Injectable Market by Country
6.2 Asia Pacific Oral Market by Country
6.3 Asia Pacific Others Market by Country
Chapter 7. Asia Pacific Rare Diseases Treatment Market by Therapeutic Area
7.1 Asia Pacific Cancer Market by Country
7.2 Asia Pacific Cardiovascular Conditions Market by Country
7.3 Asia Pacific Infectious Diseases Market by Country
7.4 Asia Pacific Musculoskeletal Conditions Market by Country
7.5 Asia Pacific Endocrine Disorders Market by Country
7.6 Asia Pacific Metabolic Disorders Market by Country
7.7 Asia Pacific Hematologic Disorders Market by Country
7.8 Asia Pacific Neurological Conditions Market by Country
7.9 Asia Pacific Others Market by Country
Chapter 8. Asia Pacific Rare Diseases Treatment Market by Country
8.1 China Rare Diseases Treatment Market
8.1.1 China Rare Diseases Treatment Market by Drug Type
8.1.2 China Rare Diseases Treatment Market by Distribution Channel
8.1.3 China Rare Diseases Treatment Market by Route of Administration
8.1.4 China Rare Diseases Treatment Market by Therapeutic Area
8.2 Japan Rare Diseases Treatment Market
8.2.1 Japan Rare Diseases Treatment Market by Drug Type
8.2.2 Japan Rare Diseases Treatment Market by Distribution Channel
8.2.3 Japan Rare Diseases Treatment Market by Route of Administration
8.2.4 Japan Rare Diseases Treatment Market by Therapeutic Area
8.3 India Rare Diseases Treatment Market
8.3.1 India Rare Diseases Treatment Market by Drug Type
8.3.2 India Rare Diseases Treatment Market by Distribution Channel
8.3.3 India Rare Diseases Treatment Market by Route of Administration
8.3.4 India Rare Diseases Treatment Market by Therapeutic Area
8.4 South Korea Rare Diseases Treatment Market
8.4.1 South Korea Rare Diseases Treatment Market by Drug Type
8.4.2 South Korea Rare Diseases Treatment Market by Distribution Channel
8.4.3 South Korea Rare Diseases Treatment Market by Route of Administration
8.4.4 South Korea Rare Diseases Treatment Market by Therapeutic Area
8.5 Singapore Rare Diseases Treatment Market
8.5.1 Singapore Rare Diseases Treatment Market by Drug Type
8.5.2 Singapore Rare Diseases Treatment Market by Distribution Channel
8.5.3 Singapore Rare Diseases Treatment Market by Route of Administration
8.5.4 Singapore Rare Diseases Treatment Market by Therapeutic Area
8.6 Malaysia Rare Diseases Treatment Market
8.6.1 Malaysia Rare Diseases Treatment Market by Drug Type
8.6.2 Malaysia Rare Diseases Treatment Market by Distribution Channel
8.6.3 Malaysia Rare Diseases Treatment Market by Route of Administration
8.6.4 Malaysia Rare Diseases Treatment Market by Therapeutic Area
8.7 Rest of Asia Pacific Rare Diseases Treatment Market
8.7.1 Rest of Asia Pacific Rare Diseases Treatment Market by Drug Type
8.7.2 Rest of Asia Pacific Rare Diseases Treatment Market by Distribution Channel
8.7.3 Rest of Asia Pacific Rare Diseases Treatment Market by Route of Administration
8.7.4 Rest of Asia Pacific Rare Diseases Treatment Market by Therapeutic Area
Chapter 9. Company Profiles
9.1 AbbVie, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Acquisition and Mergers:
9.3 Bayer AG
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.4 Novartis AG
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Approval and Trails:
9.5 Merck Group
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Acquisition and Mergers:
9.6 Bristol Myers Squibb Company
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expenses
9.6.5 Recent strategies and developments:
9.6.5.1 Acquisition and Mergers:
9.7 Pfizer, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Regional & Segmental Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.5.2 Acquisitions and Mergers:
9.8 AstraZeneca PLC
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 Recent strategies and developments:
9.8.5.1 Partnerships, Collaborations, and Agreements:
9.8.5.2 Acquisition and Mergers:
9.9 Takeda Pharmaceutical Company Limited
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.5.2 Acquisition and Mergers:
9.10. PTC Therapeutics, Inc.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 Recent strategies and developments:
9.10.5.1 Partnerships, Collaborations, and Agreements:
9.10.5.2 Acquisition and Mergers:
TABLE 1 Asia Pacific Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements – Rare Disease Treatment Market
TABLE 4 Acquisition and Mergers – Rare Disease Treatment Market
TABLE 5 Approvals and Trials – Rare Disease Treatment Market
TABLE 6 Asia Pacific Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 7 Asia Pacific Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 8 Asia Pacific Biologics Market by Country, 2018 - 2021, USD Million
TABLE 9 Asia Pacific Biologics Market by Country, 2022 - 2028, USD Million
TABLE 10 Asia Pacific Biosimilar Market by Country, 2018 - 2021, USD Million
TABLE 11 Asia Pacific Biosimilar Market by Country, 2022 - 2028, USD Million
TABLE 12 Asia Pacific Small Molecule Market by Country, 2018 - 2021, USD Million
TABLE 13 Asia Pacific Small Molecule Market by Country, 2022 - 2028, USD Million
TABLE 14 Asia Pacific Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 15 Asia Pacific Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 16 Asia Pacific Specialty Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 17 Asia Pacific Specialty Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 18 Asia Pacific Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 19 Asia Pacific Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 20 Asia Pacific Online Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 21 Asia Pacific Online Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 22 Asia Pacific Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 23 Asia Pacific Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 24 Asia Pacific Injectable Market by Country, 2018 - 2021, USD Million
TABLE 25 Asia Pacific Injectable Market by Country, 2022 - 2028, USD Million
TABLE 26 Asia Pacific Oral Market by Country, 2018 - 2021, USD Million
TABLE 27 Asia Pacific Oral Market by Country, 2022 - 2028, USD Million
TABLE 28 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 29 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 30 Asia Pacific Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 31 Asia Pacific Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 32 Asia Pacific Cancer Market by Country, 2018 - 2021, USD Million
TABLE 33 Asia Pacific Cancer Market by Country, 2022 - 2028, USD Million
TABLE 34 Asia Pacific Cardiovascular Conditions Market by Country, 2018 - 2021, USD Million
TABLE 35 Asia Pacific Cardiovascular Conditions Market by Country, 2022 - 2028, USD Million
TABLE 36 Asia Pacific Infectious Diseases Market by Country, 2018 - 2021, USD Million
TABLE 37 Asia Pacific Infectious Diseases Market by Country, 2022 - 2028, USD Million
TABLE 38 Asia Pacific Musculoskeletal Conditions Market by Country, 2018 - 2021, USD Million
TABLE 39 Asia Pacific Musculoskeletal Conditions Market by Country, 2022 - 2028, USD Million
TABLE 40 Asia Pacific Endocrine Disorders Market by Country, 2018 - 2021, USD Million
TABLE 41 Asia Pacific Endocrine Disorders Market by Country, 2022 - 2028, USD Million
TABLE 42 Asia Pacific Metabolic Disorders Market by Country, 2018 - 2021, USD Million
TABLE 43 Asia Pacific Metabolic Disorders Market by Country, 2022 - 2028, USD Million
TABLE 44 Asia Pacific Hematologic Disorders Market by Country, 2018 - 2021, USD Million
TABLE 45 Asia Pacific Hematologic Disorders Market by Country, 2022 - 2028, USD Million
TABLE 46 Asia Pacific Neurological Conditions Market by Country, 2018 - 2021, USD Million
TABLE 47 Asia Pacific Neurological Conditions Market by Country, 2022 - 2028, USD Million
TABLE 48 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 49 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 50 Asia Pacific Rare Diseases Treatment Market by Country, 2018 - 2021, USD Million
TABLE 51 Asia Pacific Rare Diseases Treatment Market by Country, 2022 - 2028, USD Million
TABLE 52 China Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 53 China Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 54 China Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 55 China Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 56 China Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 57 China Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 58 China Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 59 China Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 60 China Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 61 China Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 62 Japan Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 63 Japan Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 64 Japan Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 65 Japan Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 66 Japan Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 67 Japan Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 68 Japan Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 69 Japan Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 70 Japan Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 71 Japan Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 72 India Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 73 India Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 74 India Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 75 India Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 76 India Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 77 India Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 78 India Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 79 India Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 80 India Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 81 India Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 82 South Korea Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 83 South Korea Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 84 South Korea Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 85 South Korea Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 86 South Korea Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 87 South Korea Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 88 South Korea Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 89 South Korea Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 90 South Korea Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 91 South Korea Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 92 Singapore Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 93 Singapore Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 94 Singapore Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 95 Singapore Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 96 Singapore Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 97 Singapore Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 98 Singapore Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 99 Singapore Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 100 Singapore Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 101 Singapore Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 102 Malaysia Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 103 Malaysia Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 104 Malaysia Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 105 Malaysia Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 106 Malaysia Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 107 Malaysia Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 108 Malaysia Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 109 Malaysia Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 110 Malaysia Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 111 Malaysia Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 112 Rest of Asia Pacific Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 113 Rest of Asia Pacific Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 114 Rest of Asia Pacific Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 115 Rest of Asia Pacific Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 116 Rest of Asia Pacific Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 117 Rest of Asia Pacific Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 118 Rest of Asia Pacific Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 119 Rest of Asia Pacific Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 120 Rest of Asia Pacific Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 121 Rest of Asia Pacific Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 122 Key information – AbbVie, Inc.
TABLE 123 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 124 Key Information – Bayer AG
TABLE 125 Key Information – Novartis AG
TABLE 126 key Information – Merck GrouP
TABLE 127 Key Information – Bristol Myers Squibb Company
TABLE 128 Key Information – Pfizer, Inc.
TABLE 129 KEY INFORMATION – ASTRAZENECA PLC
TABLE 130 Key Information – Takeda Pharmaceutical Company Limited
TABLE 131 Key Information – PTC Therapeutics, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Acquisitions and Mergers: 2018, Jul – 2022, Aug) Leading Players
FIG 5 Recent strategies and developments: Pfizer, Inc.
FIG 6 Recent strategies and developments: PTC Therapeutics, Inc.